SUDA Pharmaceuticals Ltd. has partnered with ProClinical Executive Search, part of the ProClinical Group, to appoint Andrew Curtis as Vice President, Business Development & Alliance Management to be based in the USA. Andrew has considerable experience as a senior leader in a number of companies. He was, until recently, the President and CEO of Affimed US where he was responsible for building the US presence and refining the business development efforts that culminated in several key partnerships and agreements. Andrew will commence on 15 October 2018.